US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. June 24, 2026

    Judge OKs Purdue Claims Trustee, Distribution Rules

    The New York bankruptcy judge presiding over the Chapter 11 case of former OxyContin maker Purdue Pharma on Wednesday approved the appointment of a trustee to administer neonatal abstinence syndrome claims and the adoption of distribution procedures to claimants who are still minors.

  2. May 20, 2026

    Late Claims Allowed To Move Ahead In Purdue Pharma Ch. 11

    A New York bankruptcy judge on Wednesday agreed to allow 13 late-filed claims to move forward in former pharmaceutical company Purdue Pharma's Chapter 11 after its plan took effect earlier this month.

  3. May 15, 2026

    What's Happening In Bankruptcy Court This Coming Week

    QVC will seek final approval of its bankruptcy funding, e-commerce group Food52 will vie for confirmation of its liquidation plan, and First Brands Group will also court a judge's approval of its Chapter 11 plan.

  4. May 05, 2026

    Members Of Purdue Public Record Disclosure Board Named

    Entities representing groups of opioid claimants in the Chapter 11 case of Purdue Pharma have named their representatives on an oversight board created to implement a public repository of documents related to the national opioid epidemic and Purdue's role in the crisis.

  5. May 04, 2026

    Purdue Settlement Approved, Saks Gets Plan Disclosure OK

    Purdue Pharma received the green light for a settlement on its road out of Chapter 11, a Texas bankruptcy judge gave the all-clear to Saks Global's plan disclosure, and Spirit Airlines said it would undergo a shutdown instead of a government-backed rescue.

  6. April 30, 2026

    Purdue's $125M McKinsey Deal Gets OK Ahead Of Ch. 11 Exit

    Purdue Pharma LP on Thursday secured a New York bankruptcy judge's approval of a $125 million agreement with McKinsey & Co. that settles claims tied to the consulting firm's work advising Purdue on the sale and marketing of opioids, clearing the way for the pharmaceutical company to exit Chapter 11 and put its $7.4 billion bankruptcy plan into effect.

  7. April 28, 2026

    Purdue Pharma's $5.5B Plea Deal Clinched As Survivors Protest

    OxyContin maker Purdue Pharma LP has to pay a $3.5 billion fine and forfeit an additional $2 billion, more than five years after it pled guilty to criminal charges related to its role in the opioid crisis, a New Jersey federal judge said Tuesday.

  8. April 24, 2026

    What's Happening In Bankruptcy Court This Coming Week

    A New York bankruptcy judge will consider whether the state's attorney general should be a creditor in a Roman Catholic diocese's Chapter 11, Purdue Pharma will receive its criminal sentence, and Saks Global Enterprises LLC will seek court approval of a plan disclosure statement.

  9. April 21, 2026

    Purdue Pharma Sentencing Punted For In-Person Attendance

    A New Jersey federal judge delayed Oxycontin maker Purdue Pharma's criminal sentencing by a week, saying rescheduling would give an in-person attendance option to hundreds of observers who tuned in virtually Tuesday.

  10. April 17, 2026

    What's Happening In Bankruptcy Court This Coming Week

    Purdue Pharma will undergo an omnibus hearing and get criminally sentenced, Office Properties Income Trust will seek plan confirmation and Spirit will vie for the all-clear to take a vote on its own plan.